Pfiz­er to be­gin Ha­le­on ex­it in com­ing months — re­port

Pfiz­er will be­gin a “slow and me­thod­i­cal” ex­it of its 32% stake in Ha­le­on in the com­ing months, the com­pa­ny’s CFO told the Fi­nan­cial Times. 

The phar­ma gi­ant first an­nounced plans to sell its stake last June, rough­ly a month be­fore Ha­le­on de­buted on the Lon­don Stock Ex­change. The GSK spin­out was formed when Pfiz­er and GSK’s con­sumer health busi­ness­es merged in 2019, and holds pop­u­lar brands such as Sen­so­dyne tooth­paste, Ther­aflu and Advil.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.